Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-013919
Filing Date
2025-02-14
Accepted
2025-02-14 14:25:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8941
  Complete submission text file 0001104659-25-013919.txt   10661
Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 415-877-4887
Foresite Capital Fund VI LP (Filed by) CIK: 0001932516 (see all company filings)

EIN.: 881506258 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Subject) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94211 | Film No.: 25626790
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)